Skip to Content

L350 (Desvenlafaxine Succinate Extended-Release 100 mg)

Pill with imprint L350 is Red, Round and has been identified as Desvenlafaxine Succinate Extended-Release 100 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L350

Desvenlafaxine Succinate Extended-Release

Imprint
L350
Strength
100 mg
Color
Red
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Manufacturer
Alembic Pharmaceuticals Limited
National Drug Code (NDC)
51991-0312

Get help with Imprint Code FAQs.

Related Images for "L350"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.